Jane Street
JNP

Jane Street’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Jane Street’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,276
Closed -$104K – 6004
2018
Q1 		$104K Buy
+10,276
New +$86.3K ﹤0.01% 4596
2015
Q4 		– Sell
-11,804
Closed -$139K – 4717
2015
Q3 		$139K Buy
+11,804
New +$130K ﹤0.01% 3302

Other funds holding JNP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jane Street's JNP Position: Q2 2018 in Review

Jane Street sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2018, closing a stake of 10,276 shares — an estimated $104K sold.

Jane Street first reported a position in JNP in Q3 2015 and held it in 2 quarters. The position peaked at $139K in Q3 2015. 48 funds tracked by Wall St. Rank hold JNP as of Q2 2018.

  • Jane Street reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Jane Street sold 10,276 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $104K.
  • Jane Street first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • Jane Street's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $139K in Q3 2015.
  • 48 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on Jane Street's 13F filing for Q2 2018, filed 15 Aug 2018.